Combined abiraterone acetate plus prednisone, salvage prostate bed radiotherapy and LH-RH agonists (CARLHA-GEP12) in biochemically-relapsing prostate cancer patients following prostatectomy: A phase I study of the GETUG/GEP

BACKGROUND: To establish the maximum tolerated dose of abiraterone acetate plus prednisone (AA) combined with salvage radiotherapy (SRT) and goserelin in a phase 1 study in men with rising PSA following radical prostatectomy. METHODS: AA was given during one month before SRT at 1000 mg PO once daily...

Descripción completa

Detalles Bibliográficos
Autores principales: Supiot, Stéphane, Campion, Loic, Pommier, Pascal, Dore, Mélanie, Palpacuer, Clément, Racadot, Séverine, Rio, Emmanuel, Milano, Gérard A., Mahier - Ait Oukhatar, Céline, Carrie, Christian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2018
Materias:
Clinical Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5955159/
https://www.ncbi.nlm.nih.gov/pubmed/29774129
http://dx.doi.org/10.18632/oncotarget.25189

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5955159/
https://www.ncbi.nlm.nih.gov/pubmed/29774129
http://dx.doi.org/10.18632/oncotarget.25189

Ejemplares similares